Cidara Therapeutics Inc (NASDAQ:CDTX)

2.01
Delayed Data
As of May 07
 -0.01 / -0.50%
Today’s Change
1.82
Today|||52-Week Range
4.45
+0.50%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Cidara Therapeutics Inc have a median target of 6.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +198.51% increase from the last price of 2.01.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Cidara Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$7.9M
Reporting Date
May 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 31.63%
 
 
 
 
 
 
Growthannually 26.00%
 
 
 
 
 
 

Sales

Growthquarterly 111.23%
 
 
 
 
 
 
Growthannually 121.39%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.